当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析

华北制药

(600812)

  

流通市值:101.74亿  总市值:101.74亿
流通股本:17.16亿   总股本:17.16亿

华北制药(600812)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.12亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益667402.86万元,未分配利润-42309.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2153728.49万元,负债1486325.63万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入7,484,828,636.645,275,037,790.22,574,254,051.929,869,575,819.11
营业总成本7,258,017,573.935,064,452,841.412,469,225,602.079,602,162,210.85
其他经营收益
营业利润286,904,212.36213,773,689.18102,915,436.03311,681,160.94
利润总额287,215,555.62214,036,244.45103,152,262.47309,832,512.76
净利润211,538,869.17162,286,856.676,625,661.99214,966,518.33
每股收益
其他综合收益-209,831.87-412,469.0239,722.881,601,601.48
综合收益总额211,329,037.3161,874,387.5876,665,384.87216,568,119.81
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计8,336,620,392.118,564,390,541.758,794,547,086.898,259,279,869.84
非流动资产:
非流动资产合计13,200,664,532.4513,188,551,499.1713,199,484,516.5213,212,178,446.59
资产总计21,537,284,924.5621,752,942,040.9221,994,031,603.4121,471,458,316.43
流动负债:
流动负债合计12,409,673,422.3812,108,718,070.5612,025,521,079.6810,961,529,998.42
非流动负债:
非流动负债合计2,453,582,912.282,919,971,517.193,216,638,803.663,835,315,230.43
负债合计14,863,256,334.6615,028,689,587.7515,242,159,883.3414,796,845,228.85
所有者权益(或股东权益):
归属于母公司股东权益合计5,505,224,974.655,467,083,266.955,447,527,540.655,389,402,984.11
股东权益合计6,674,028,589.96,724,252,453.176,751,871,720.076,674,613,087.58
负债和股东权益合计21,537,284,924.5621,752,942,040.9221,994,031,603.4121,471,458,316.43
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计5,641,276,009.823,545,924,571.691,634,519,3217,861,279,183.7
经营活动现金流出小计4,979,830,131.483,054,426,514.781,471,205,501.616,631,713,783.97
经营活动产生的现金流量净额661,445,878.34491,498,056.91163,313,819.391,229,565,399.73
投资活动产生的现金流量:
投资活动现金流入小计60,596,232.860,008,20060,006,900511,985,618.04
投资活动现金流出小计680,002,187.69235,625,353.31120,585,892.861,458,717,313.8
投资活动产生的现金流量净额-619,405,954.89-175,617,153.31-60,578,992.86-946,731,695.76
筹资活动产生的现金流量:
筹资活动现金流入小计7,060,360,0004,517,450,0001,976,350,00011,701,445,416.67
筹资活动现金流出小计7,193,011,402.25,031,506,160.341,963,386,231.4611,238,708,445.73
筹资活动产生的现金流量净额-132,651,402.2-514,056,160.3412,963,768.54462,736,970.94
汇率变动对现金及现金等价物的影响3,040,427.583,877,130.092,527,048.3711,828,701.55
现金及现金等价物净增加额-87,571,051.17-194,298,126.65118,225,643.44757,399,376.46
期末现金及现金等价物余额1,174,832,901.851,068,105,826.371,380,629,596.461,262,403,953.02
补充资料:
现金及现金等价物的净增加额--194,298,126.65-757,399,376.46
TOP↑